Clinical Trial Update: Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing dexlansoprazole with double-dose lansoprazole in obesity-related reflux esophagitis; study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Reflux Esophagitis

Drugs mentioned

• DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN